YTEN Stock Overview
Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Yield10 Bioscience, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.32 |
| 52 Week High | US$4.19 |
| 52 Week Low | US$0.31 |
| Beta | 1.82 |
| 1 Month Change | -27.25% |
| 3 Month Change | -83.41% |
| 1 Year Change | -90.30% |
| 3 Year Change | -96.06% |
| 5 Year Change | -99.45% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Yield10 Bioscience GAAP EPS of $0.70 beats by $1.39, revenue of $0.1M misses by $0.06M
Aug 10Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?
Nov 12
Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans
Jul 19Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year
May 18Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation
Apr 14Yield10 Bio secures $12.7M capital raise
Feb 01Yield10 Bioscience under pressure on launching stock offering
Jan 29When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?
Jan 22
We're Keeping An Eye On Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Rate
Nov 23Yield10 Bioscience, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 13Shareholder Returns
| YTEN | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -13.9% | -1.8% | -3.1% |
| 1Y | -90.3% | 10.3% | 15.1% |
Return vs Industry: YTEN underperformed the US Biotechs industry which returned 10.3% over the past year.
Return vs Market: YTEN underperformed the US Market which returned 15.1% over the past year.
Price Volatility
| YTEN volatility | |
|---|---|
| YTEN Average Weekly Movement | 20.9% |
| Biotechs Industry Average Movement | 9.0% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in US Market | 14.2% |
| 10% least volatile stocks in US Market | 2.5% |
Stable Share Price: YTEN is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 21% a week.
Volatility Over Time: YTEN's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 30 | Olly Peoples | https://www.yield10bio.com |
Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions.
Yield10 Bioscience, Inc. Fundamentals Summary
| YTEN fundamental statistics | |
|---|---|
| Market Cap | US$3.79m |
| Earnings (TTM) | -US$14.25m |
| Revenue (TTM) | US$258.00k |
14.7x
P/S Ratio-0.3x
P/E RatioIs YTEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YTEN income statement (TTM) | |
|---|---|
| Revenue | US$258.00k |
| Cost of Revenue | US$8.13m |
| Gross Profit | -US$7.87m |
| Other Expenses | US$6.38m |
| Earnings | -US$14.25m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.20 |
| Gross Margin | -3,051.16% |
| Net Profit Margin | -5,525.19% |
| Debt/Equity Ratio | 165.4% |
How did YTEN perform over the long term?
See historical performance and comparison